EP
CRIS icon

Eudaimonia Partners’s Curis CRIS Stock Holding History

Eudaimonia Partners’s Portfolio CRIS Stock Details CRIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50
Closed -$14K – 740
2020
Q1 		$14K Buy
50
+25
+100% +$13.3K 0.01% 665
2019
Q4 		$17K Buy
+25
New +$18.1K 0.01% 674

Other funds holding CRIS

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Eudaimonia Partners's CRIS Position: Q2 2020 in Review

Eudaimonia Partners sold out of Curis (CRIS) in Q2 2020, closing a stake of 50 shares — an estimated $14K sold.

Eudaimonia Partners first reported a position in CRIS in Q4 2019 and held it in 2 quarters. The position peaked at $17K in Q4 2019. 42 funds tracked by Wall St. Rank hold CRIS as of Q2 2020.

  • Eudaimonia Partners reported no remaining Curis position as of Q2 2020 after selling out during the quarter.
  • Eudaimonia Partners sold 50 Curis shares in Q2 2020, an estimated $14K.
  • Eudaimonia Partners first reported a position in Curis in Q4 2019 and held it in 2 quarters.
  • Eudaimonia Partners's Curis position peaked at $17K in Q4 2019.
  • 42 funds tracked by Wall St. Rank held Curis as of Q2 2020.

Based on Eudaimonia Partners's 13F filing for Q2 2020, filed 14 Aug 2020.